Standard concurrent chemoradiotherapy (CCRT) for cervical cancer achieves disease-free survival (DFS) in approximately 70% of patients with locally advanced disease; however, nearly 30% still ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback